Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Placing

27 Sep 2007 07:01

Plant Health Care PLC27 September 2007 Embargoed until 0700, 27 September 2007 PLANT HEALTH CARE PLC Plant Health Care plc ("the Company" or "Plant Health Care") £5 Million Equity Placing Plant Health Care plc, the provider of natural products for plant and soil care,announces that it has raised £4,993,240 (before expenses) by way of a placing of2,098,000 new ordinary shares at a price of 238 pence per share ("PlacingShares"). The Placing Shares have been placed with existing shareholders byEvolution Securities, the Company's Nominated Adviser and broker. As stated in the Company's interim results released on 24 September 2007, theCompany currently has net cash balances of approximately US$2.0 million as wellas credit facilities in place adequate for its current needs. However, followingdiscussions with a number of the Company's major shareholders, the Board hasdecided that it would be appropriate to take the opportunity to strengthen itsbalance sheet and to provide additional resources to accelerate the momentumwhich has been achieved as regards the commercialisation of Myconate and Harpin. The placing is conditional only upon Admission of the Placing Shares to AIM.Application will be made for the Placing Shares, which rank pari passu with theexisting issued trading shares, to be admitted to trading on AIM and dealingsare expected to commence on Tuesday, 2 October 2007. John Brady, Chief Executive, commented: "We are very pleased with the progress we have made towards the commercialisation of Myconate and Harpin; these additional funds enable us toinvest in the resources necessary to accelerate development". He added: "We are very appreciative of the support given by our shareholders". For Further Information:Plant Heath Care plcJohn Brady, Chief Executive27 and 28 September Tel: 020 7920 3150Thereafter: 001 603 525 3702 Evolution Securities Limited Tavistock CommunicationsTim Worlledge/Tim Redfern Jeremy Carey/Matt RidsdaleTel: 020 7071 4300 Tel: 020 7920 3150 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.